Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Non-Current Debt (2017 - 2026)

Verastem (VSTM) posted quarterly Non-Current Debt of $73.1 million for Q1 2026, up 2.3% year-over-year from $71.5 million in Q1 2025, and down 4.21% quarter-over-quarter from $76.3 million in Q4 2025.

Analysis

Verastem (VSTM) Non-Current Debt (2017 - 2026) Analysis & Trends

Verastem's Non-Current Debt history runs 9 years deep, the most recent figure standing at $73.1 million for Q1 2026.

  • In Q1 2026, Non-Current Debt rose 2.3% year-over-year to $73.1 million; the TTM figure through Mar 2026 stood at $73.1 million (up 2.3% YoY), while the FY2025 annual figure was $76.3 million, up 87.43% from the prior year.
  • Non-Current Debt for Q1 2026 stood at $73.1 million, down from $76.3 million in the prior quarter.
  • The five-year high for Non-Current Debt was $78.1 million in Q3 2025, with the low at $24.2 million in Q1 2022.
  • The 5-year median for Non-Current Debt is $39.9 million (2023), against an average of $45.7 million.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Debt fell 23.21% in 2024, then jumped 154.92% in 2025.
  • Verastem's Non-Current Debt stood at $24.5 million in 2022, then soared by 63.44% to $40.1 million in 2023, then grew by 1.59% to $40.7 million in 2024, then surged by 87.43% to $76.3 million in 2025, then slipped by 4.21% to $73.1 million in 2026.
  • Business Quant data shows VSTM's Non-Current Debt at $73.1 million in Q1 2026, $76.3 million in Q4 2025, and $78.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 591.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 882.16 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 8.96 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 546.77 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn 73.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73.77 Mn
Mar 31, 2026 73.12 Mn
Dec 31, 2025 76.33 Mn
Sep 30, 2025 78.12 Mn
Jun 30, 2025 74.27 Mn
Mar 31, 2025 71.48 Mn
Dec 31, 2024 40.72 Mn
Sep 30, 2024 30.65 Mn
Jun 30, 2024 35.39 Mn
Mar 31, 2024 40.12 Mn
Dec 31, 2023 40.09 Mn
Sep 30, 2023 39.91 Mn
Jun 30, 2023 39.74 Mn
Mar 31, 2023 39.57 Mn
Dec 31, 2022 24.53 Mn
Sep 30, 2022 24.40 Mn
Jun 30, 2022 24.28 Mn
Mar 31, 2022 24.16 Mn
Sep 30, 2020 35.70 Mn
Jun 30, 2020 35.50 Mn